New Multi-Targeting Strategy in Hair Growth Promotion: In Vitro and In Vivo Studies

    May 2018 in “ Italian journal of dermatology and venereology ”
    Barbara Mora, Daniela Pinto, Elisabetta Sorbellini, Fabio Rinaldi
    Image of study
    TLDR The lotion with N1-methylspermidine and Sandalore® effectively reduces hair loss and promotes hair growth.
    The study, conducted 5 years ago, investigated a new multi-targeting strategy for promoting hair growth. The researchers focused on two recently identified targets in hair cycling and growth control: olfactory receptor and autophagy. They evaluated the pro-autophagic effect of N1-methylspermidine in vitro and tested a lotion containing N1-methylspermidine and Sandalore® in a double-blind clinical trial involving 60 male and female subjects with chronic telogen effluvium. The in vitro tests showed that N1-methylspermidine increased the autophagic process. The clinical trials confirmed the safety and anti-hair loss efficacy of the lotion, with a reduction in hair loss and stimulation of hair growth observed after 3 months of treatment. These effects remained statistically significant, except for hair lost during wash, even 3 months after the end of treatment. The study concluded that the daily use of the N1-methylspermidine and Sandalore®-based lotion effectively counteracts hair loss and increases hair growth.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 324 results

      community Average r/bald user complaining

      in Satire  386 upvotes 6 days ago
      Hair loss treatments like Minoxidil, finasteride, and RU58841, focusing on their effectiveness and side effects. It also highlights the disparity in medical research funding between hair loss and conditions like endometriosis.

      community 4 months finasteride + minoxidil combo spray

      in Progress Pictures  487 upvotes 7 months ago
      The user has been using a finasteride and minoxidil combo spray from Hims for four months, with positive results and no side effects. They apply four sprays nightly, targeting the crown and front of the scalp.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  135 upvotes 1 year ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

      community PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance

      in Research/Science  122 upvotes 2 years ago
      The phase 3 trial results for Pyrilutamide showed no significant difference from the control treatment in increasing hair count, leading to the company halting its development. Users discussed their disappointment and skepticism about hair loss treatments, with some mentioning other treatments like Minoxidil, Finasteride, and RU58841.

      community Exosomes + Topical Minoxidil (9-months progress and details)

      in Progress Pictures  4 upvotes 1 year ago
      The user shared their 9-month progress using exosomes and topical minoxidil for hair loss, concluding that minoxidil was more effective for them than exosomes. They plan to continue using minoxidil and have started finasteride while managing dandruff with salicylic acid.

    Related Research

    4 / 4 results